RIMANTADINE TREATMENT OF ACUTE INFLUENZA A VIRUS INFECTION

金刚乙胺治疗急性甲型流感病毒感染

• 批准号: 3886034
• 负责人: STEPHEN B GREENBERG
• 金额: --
• 依托单位: BAYLOR COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3886034
• 关键词: acute disease /disorder; amantadine; antiviral agents; drug administration routes; drug adverse effect; drug tolerance; human subject; human therapy evaluation; respiratory disorder chemotherapy; respiratory infections; viral pneumonia

The purpose of this study is to examine the safety, tolerance, and pharmacokinetics of rimatadine by small particle aerosol and to compare the efficacy of rimantadine by mouth and by small particle aerosol in the treatment of acute influenza A virus infection.

本研究的目的是检查安全性、耐受性和 小颗粒气雾剂的金刚乙胺药代动力学并比较 金刚乙胺口服和小颗粒气雾剂的功效 治疗急性甲型流感病毒感染。